Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Liquid Biopsy Surveillance and Early Detection Summit

Evvnt Promotion / evvnt
-
16.11.2022 - 17.11.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
 
Kongressthemen
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1315351-3?pid=4832

Speakers: Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1315351-2?pid=4832
Herr Alex Domingo
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developers and Academics Conference Pass: USD 0.50, Commercial Vendors Conference Pass: USD 3599.00, Technical Vendors Conference Pass: USD 2599.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

newTreeÖsterreichische Akademie der ÄrzteAlumni Club Medizinische Universität WienCharité International AcademyHelix - Forschung & Beratung WienÄrzte der WeltOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.